1. OPUS at UTS

Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
2008-01Método Dáder Para El Seguimiento Farmacoterapéutico En La Atención HospitalariaSilva-Castro, MM; Calleja-Hernandez, MA; Tuneu, I; Valls, L; Machuca, M; Sabater Hernandez, D; Faus, MJ; Silva Castro, MM; Calleja Hernandez, MA; Tuneu, I; Valls, L; Faus Dader, MJ
2008-01-01Anticoagulation control in hospitalised patients on warfarinSu, EY; Naganathan, V; Fallah, H; Bajorek, BV; McLachlan, AJ
2008-03-12Structure and organization of phospholipid/polysaccharide nanoparticlesGerelli, Y; Di Bari, MT; Deriu, A; Cantu, L; Colombo, P; Como, C; Motta, S; Sonvico, F; May, R
2008-01-01Exploring point-of-care testing of capillary blood in warfarin managementGlover, S; Bajorek, BV
2008-08-01Treating asthma means treating airway smooth muscle cellsZuyderduyn, S; Sukkar, MB; Fust, A; Dhaliwal, S; Burgess, JK
2008-04-01Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscleOltmanns, U; Walters, M; Sukkar, M; Xie, S; Issa, R; Mitchell, J; Johnson, M; Chung, KF
2008-12-01Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practiceVermeer, NS; Bajorek, BV
2008-10-21Structure of self-organized multilayer nanoparticles for drug deliveryGerelli, Y; Barbieri, S; Di Bari, MT; Deriu, A; Cantù, L; Brocca, P; Sonvico, F; Colombo, P; May, R; Motta, S
2008-01Efecto del Metodo Dader de Seguimiento Farmacoterapéutico en el riesgo cardiovascular de pacientes con factores de riesgo o enfermedad cardiovascular (EMDADER-CV): Metodos y resultados globalesAmariles, P; Faus, MJ; Jimenez- Martin, J; Sabater Hernandez, D; Garcia-Jimenez, E
2008-04-01Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by Gram-positive and Gram-negative bacteria in human airway smooth muscle cellsIssa, R; Sorrentino, R; Sukkar, MB; Sriskandan, S; Chung, KF; Mitchell, JA
Results 1-10 of 25 (Search time: 0.251 seconds).

Discover